Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis ; volume:17 ; number:1 ; day:15 ; month:6 ; year:2020 ; pages:1-21 ; date:12.2020
Journal of neuroinflammation ; 17, Heft 1 (15.6.2020), 1-21, 12.2020
- Creator
-
Gilmore, Wendy
Lund, Brett T.
Li, Peili
Levy, Alex M.
Kelland, Eve E.
Akbari, Omid
Groshen, Susan
Cen, Steven Yong
Pelletier, Daniel
Weiner, Leslie P.
Javed, Adil
Dunn, Jeffrey E.
Traboulsee, Anthony L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-020-01847-9
- URN
-
urn:nbn:de:101:1-2020093023064618605014
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gilmore, Wendy
- Lund, Brett T.
- Li, Peili
- Levy, Alex M.
- Kelland, Eve E.
- Akbari, Omid
- Groshen, Susan
- Cen, Steven Yong
- Pelletier, Daniel
- Weiner, Leslie P.
- Javed, Adil
- Dunn, Jeffrey E.
- Traboulsee, Anthony L.
- SpringerLink (Online service)
Other Objects (12)
Postural Control in Relapsing-Remitting Multiple Sclerosis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Relapsing/remitting type 1 diabetes
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis
Longitudinal structural network reorganisation in early relapsing-remitting multiple sclerosis [Abstract]
Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
Postural Control in Relapsing-Remitting Multiple Sclerosis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Relapsing/remitting type 1 diabetes
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis
Longitudinal structural network reorganisation in early relapsing-remitting multiple sclerosis [Abstract]
Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis
Postural Control in Relapsing-Remitting Multiple Sclerosis
Abnormal multisensory integration in relapsing–remitting multiple sclerosis
Relapsing/remitting type 1 diabetes
Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis
Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing-remitting multiple sclerosis
Longitudinal cortical network reorganization in early relapsing–remitting multiple sclerosis
Correlates and trajectories of relapses in relapsing–remitting multiple sclerosis
Discontinuation and dose reduction of rituximab in relapsing–remitting multiple sclerosis
Longitudinal structural network reorganisation in early relapsing-remitting multiple sclerosis [Abstract]